(3-((Trimethylsilyl)ethynyl)phenyl)methanol, 95%, 10g

4-(Bromomethyl)-2-methoxypyridine hydrobromide, 98%, 5g

4-(10H-Phenoxazin-10-yl)benzaldehyde, 97%, 100mg

2-Chloro-3-fluorophenol, 99.0%, 5g

(S)-1-(Cyclopropylmethyl)pyrrolidine-2-carboxylic acid, 95.0%, 100mg

2,5-Dichloroiodobenzene, 98.0%, 1g

1-sec-butyl-3-nitro-1H-pyrazole, 1g

4-Bromo-1,3-benzothiazole, 97.0%, 5g

3-(3-Fluorophenyl)oxetane-3-carboxylic acid, 98%, 100mg

2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide, 98.0%, 25g

Phase contrast slide set with 20x and S100x PLPHi IOS infinity corrected objectives and phase contrast rings for 20x/S100x

Methyl 4-((diethoxyphosphoryl)methyl)benzoate, 98%, 1g

1-(Indolin-1-yl)ethan-1-one>95.0%(GC)(T)5g